View in EDS HTML Full Text PDF Full Text

A comprehensive analysis of humanized mouse models for the study of cancer immunotherapies.

Saved in:
Bibliographic Details
Title: A comprehensive analysis of humanized mouse models for the study of cancer immunotherapies.
Authors: De La Rochere P; Institut national de la santé et de la recherche médicale (INSERM) U932, and SIRIC Translational Immunotherapy Team, Translational Research Department, Institut Curie, PSL Research University, Paris, France., Loumagne L; Sanofi Oncology, Vitry Sur Seine, France., Rathaux M; Institut national de la santé et de la recherche médicale (INSERM) U932, and SIRIC Translational Immunotherapy Team, Translational Research Department, Institut Curie, PSL Research University, Paris, France., Dubois M; Institut national de la santé et de la recherche médicale (INSERM) U932, and SIRIC Translational Immunotherapy Team, Translational Research Department, Institut Curie, PSL Research University, Paris, France., Denizeau J; Institut national de la santé et de la recherche médicale (INSERM) U932, and SIRIC Translational Immunotherapy Team, Translational Research Department, Institut Curie, PSL Research University, Paris, France., Nemati F; Laboratory of Preclinical Investigation, Translational Research Department, Institut Curie, PSL Research University, Paris, France., Viel S; Institut national de la santé et de la recherche médicale (INSERM) U932, and SIRIC Translational Immunotherapy Team, Translational Research Department, Institut Curie, PSL Research University, Paris, France., Rocha D; Institut national de la santé et de la recherche médicale (INSERM) U932, and SIRIC Translational Immunotherapy Team, Translational Research Department, Institut Curie, PSL Research University, Paris, France., Slavnic T; IT&M STATS, Groupe IT&M, Neuilly-sur-Seine, France., Thatte J; Crown Bioscience Inc., San Diego, CA, United States., Li HQ; Crown Bioscience Inc., San Diego, CA, United States., Ouyang X; Crown Bioscience Inc., San Diego, CA, United States., Sedlik C; Institut national de la santé et de la recherche médicale (INSERM) U932, and SIRIC Translational Immunotherapy Team, Translational Research Department, Institut Curie, PSL Research University, Paris, France., Decaudin D; Laboratory of Preclinical Investigation, Translational Research Department, Institut Curie, PSL Research University, Paris, France.; Department of Medical Oncology, Institut Curie, Paris, France., Azar G; Sanofi Oncology, Vitry Sur Seine, France., Sidhu S; Sanofi Oncology, Vitry Sur Seine, France., Piaggio E; Institut national de la santé et de la recherche médicale (INSERM) U932, and SIRIC Translational Immunotherapy Team, Translational Research Department, Institut Curie, PSL Research University, Paris, France.
Source: Frontiers in immunology [Front Immunol] 2026 Apr 07; Vol. 17, pp. 1730378. Date of Electronic Publication: 2026 Apr 07 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1664-3224
DOI:10.3389/fimmu.2026.1730378